Why is Amerise BioScie falling/rising?

As of 10-Sep, Amerise Biosciences Ltd is currently priced at 0.70, showing no change (0.00%). The stock has underperformed its sector by 0.92% today and is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a downward trend. Over the past week, the stock has declined by 1.41%, while it has seen a slight increase of 1.45% over the past month. However, the year-to-date performance is significantly negative, with a decline of 42.15%. Notably, there has been a rise in investor participation, with delivery volume increasing by 127.57% compared to the 5-day average, which may suggest some interest despite the overall negative performance. There is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, the Sensex has increased by 1.06% over the past week, contrasting with Amerise Biosciences' decline of 1.41%. This indicates that while the overall market is experiencing gains, Amerise is lagging behind significantly. Over the past month, the benchmark has also outperformed the stock, with a return of 1.96% compared to Amerise's 1.45%. The stark difference in performance highlights the challenges faced by Amerise in attracting investor confidence relative to the broader market trends.